https://www.zacks.com/stock/news/2232608/holx-or-ew-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2232608
Feb 27, 2024 - HOLX vs. EW: Which Stock Is the Better Value Option?
zc:7116373311381668629
0
https://www.zacks.com/stock/news/2240686/buy-5-medical-devices-stocks-for-a-stable-portfolio-in-2024?cid=CS-ZC-FT-analyst_blog|investment_ideas-2240686
Mar 14, 2024 - We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
zc:5542515259158012972
0
https://www.zacks.com/stock/news/2247654/here-s-why-investors-should-hold-teladoc-tdoc-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2247654
Mar 28, 2024 - Teladoc's (TDOC) Integrated Care business is expected to gain from margin expansion and improving chronic care program enrollment.
zc:-7539268432179903511
0
https://www.zacks.com/stock/news/2253585/will-unitedhealth-s-unh-unitedhealthcare-unit-aid-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2253585
Apr 10, 2024 - UnitedHealth's (UNH) first-quarter results are expected to benefit from an increase in UnitedHealthcare's Community & State revenues and the number of people it served.
zc:-2163871940917110272
0
https://www.zacks.com/stock/news/2254571/what-s-in-store-for-abbott-laboratories-abt-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254571
Apr 12, 2024 - Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
zc:-5876254083692607607
0
https://www.zacks.com/commentary/2255364/3-medical-instruments-stocks-to-buy-amid-improving-industry-trends?cid=CS-ZC-FT-industry_outlook-2255364
Apr 15, 2024 - The Zacks Medical - Instruments industry is expected to gain from the rising adoption of smart healthcare options, including genAI. However, supply issues and staffing shortages continue to disrupt growth. EW, DXCM and STE appear well-poised to brave the challenges.
zc:-2583494088093073806
0
https://www.zacks.com/stock/news/2255600/what-s-in-store-for-thermo-fisher-tmo-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2255600
Apr 15, 2024 - Strength in Analytical Instrument and Laboratory Products and Services segments are likely to have driven Thermo Fisher's (TMO) first-quarter 2024 performance.
zc:3981072332015869995
0
https://www.zacks.com/stock/news/2256177/what-s-in-store-for-boston-scientific-bsx-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256177
Apr 16, 2024 - Boston Scientific (BSX) is expected to have registered strong growth in the Asia Pacific, led by strength in China, Japan and Latin America.
zc:-6457106060917456620
0
https://www.zacks.com/stock/news/2256331/unitedhealth-group-unh-tops-on-q1-earnings-reaffirms-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2256331
Apr 16, 2024 - UnitedHealth Group (UNH) first-quarter earnings benefit from strong Optum and UnitedHealthcare business lines. Rising expenses partially offset the positives.
zc:-5145192463365374898
0
https://www.zacks.com/stock/news/2256354/is-a-beat-likely-for-intuitive-surgical-isrg-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2256354
Apr 16, 2024 - Intuitive Surgical's (ISRG) first-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
zc:1981100304867191731
0